02144nam 2200601 a 450 991045241200332120200520144314.01-61761-457-2(CKB)2550000001042096(EBL)3019248(SSID)ssj0000854109(PQKBManifestationID)12308034(PQKBTitleCode)TC0000854109(PQKBWorkID)10902974(PQKB)10486015(MiAaPQ)EBC3019248(Au-PeEL)EBL3019248(CaPaEBR)ebr10670813(OCoLC)830627853(EXLCZ)99255000000104209620091020d2010 uy 0engur|n|---|||||txtccrAMPK-S6K1 signaling pathway as a target for treating hepatic insulin resistance[electronic resource] /Sang Geon Kim, Il Je Cho and Hee Yeon KayNew York Nova Science Publishersc20101 online resource (69 p.)Hepatology research and clinical developments seriesDescription based upon print version of record.1-60876-693-4 Includes bibliographical references (p. [33]-49) and index.Introduction: Insulin signaling in hepatocytes -- Clinical and preclinical drugs for the treatment of hepatic insulin resistance.Hepatology research and clinical developments series.Insulin resistanceMolecular aspecstsLiverDiseasesMolecular aspecstsProtein kinasesElectronic books.Insulin resistanceMolecular aspecsts.LiverDiseasesMolecular aspecsts.Protein kinases.616.3/6207Kim Sang Geon989903Cho Il Je989904Kay Hee Yeon989905MiAaPQMiAaPQMiAaPQBOOK9910452412003321AMPK-S6K1 signaling pathway as a target for treating hepatic insulin resistance2264172UNINA